Actively Recruiting
Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia: Randomized Multicenter Trial
Led by University Hospital, Clermont-Ferrand · Updated on 2025-12-04
120
Participants Needed
4
Research Sites
N/A
Total Duration
On this page
AI-Summary
What this Trial Is About
Children and adolescents aged 6 to 16 years with acute leukemia often experience painful and anxiety-inducing treatments, especially during needle insertions into implantable ports used for administering chemotherapy and other therapies. This trial evaluates whether repeated use over three months of interactive or hypnotic virtual reality (VR) can better manage pain and reduce anxiety for the child, their parents, and caregivers compared to the standard distraction methods during these procedures. Participants are randomly assigned to one of three groups: the standard method involving local anesthetic cream and distraction by caregivers or parents, interactive virtual reality using a VR mask with guided virtual environments, or hypnotic virtual reality using a similar mask but with hypnotic software. In both VR groups, the child wears headphones and a headset and is immersed in a virtual world starting about five minutes before the needle insertion and continuing briefly after the procedure, with local anesthetic cream applied in all groups. During the study, children and their parents will be assessed for pain and anxiety using self-evaluation scales, heart rate monitoring, and satisfaction questionnaires after each needle insertion over a three-month period. Pain is primarily measured 15 minutes after the procedure. Researchers will also monitor fear levels and heart rate before and immediately after care to understand the impact of VR on the experience. The total participation spans these repeated care sessions during the three months following randomization.
CONDITIONS
Brief Title
Evaluation of the Efficacy of a Virtual Reality When Placing a Needle on an Implantable Venous Access Device in Children With Leukemia
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Children aged 6 to 16 years with leukemia requiring needle insertion into an implantable port
- Life expectancy of 3 months or more
- Informed consent given by the child and their parents
- No contraindications to MEOPA� (including no need for 100% oxygen ventilation, no intracranial hypertension, no altered consciousness preventing cooperation)
- No contraindications to virtual reality mask use (no epilepsy or psychiatric illness)
- Ability of child and parents to use self-assessment scales
- Enrollment in the Social Security system
You will not qualify if you...
- Children with altered pain processing conditions (e.g., spina bifida)
- Children requiring contact isolation due to contagious conditions
- History of seizures
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Your Study Journey
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 3 months
Participants receive repeated weekly needle insertions into an implantable port with one of three methods: standard care with local anesthetic cream and distraction, interactive virtual reality with local anesthetic cream, or hypnotic virtual reality with local anesthetic cream. The virtual reality sessions include preparation, immersion during needle insertion, and a short period after the procedure.
Weekly visits for needle insertion and virtual reality or standard care
Duration - Up to 3 months after randomization
Participants' pain, fear, heart rate, and care evaluation are assessed during and after the treatment period to monitor outcomes.
Assessments occur before, immediately after, and 15 minutes after each care session
Trial Site Locations
Total: 4 locations
1
CHU de Bordeaux
Bordeaux, France, 33000
Actively Recruiting
2
CHU de Clermont-Ferrand
Clermont-Ferrand, France, 63000
Actively Recruiting
3
Assistance Publique - Hôpitaux de Marseille
Marseille, France, 13005
Actively Recruiting
4
CHU de Toulouse
Toulouse, France, 31059
Actively Recruiting
Research Team
L
Lise LACLAUTRE
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
RANDOMIZED
Model
PARALLEL
Primary Purpose
SUPPORTIVE_CARE
Number of Arms
3
Similar Trials
Frequently Asked Questions
Have more questions? Get in touch with our team for quick support
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here